Antiviral effect of maraviroc in semen: A case report

Antiviral Therapy

Volumn 17, Issue 5, 2012, Pages 933-936

  Pasquier, Christophe ^a   Moinard, Nathalie ^a   Sauné, Karine ^a   Daudin, Myriam ^a   Trancart, Stéphanie ^b   Massip, Patrice ^a   Izopet, Jacques ^a   Bujan, Louis ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; DARUNAVIR PLUS RITONAVIR; EMTRICITABINE; LOPINAVIR PLUS RITONAVIR; MARAVIROC; RALTEGRAVIR; TENOFOVIR; VIRUS RNA;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHLAMYDIA; CHLAMYDIASIS; CYTOMEGALOVIRUS; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; GONORRHEA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAUTERINE INSEMINATION; MALE; PRIORITY JOURNAL; SEMINAL PLASMA; SPERM; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; VIRUS LOAD; VIRUS SHEDDING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYCLOHEXANES; HIV FUSION INHIBITORS; HIV INFECTIONS; HIV-1; HUMANS; MALE; SEMEN; SPERM COUNT; TRIAZOLES; VIRAL LOAD;

EID: 84861212660     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP2038     Document Type: Article

References (18)

1. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-333.
2. Marcelin AG, Tubiana R, Lambert-Niclot S, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 2008; 22:1677-1679.
3. Halfon P, Giorgetti C, Khiri H, et al. Semen may harbor HIV despite effective HAART: another piece in the puzzle. PLoS ONE 2010; 5:e10569.
4. Sheth PM, Kovacs C, Kemal KS, et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 2009; 23:2050-2054.
5. Bujan L, Hollander L, Coudert M, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007; 21:1909-1914.
6. Pasquier C, Saune K, Raymond S, et al. Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy. J Clin Microbiol 2009; 47:2883-2887.
7. Raymond S, Delobel P, Mavigner M, et al. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. J Clin Virol 2010; 47:126-130.
8. Tachet A, Dulioust E, Salmon D, et al. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 1999; 13:823-831.
9. Pasquier CJ, Moinard N, Saune K, et al. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract. AIDS 2008; 22:1894-1896.
10. Pereira AS, Kashuba AD, Fiscus SA, et al. Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden. J Infect Dis 1999; 180:2039-2043.
11. Brown KC, Patterson KB, Malone SA, et al. Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men. J Infect Dis 2011; 203:1484-1490.
12. Kashuba AD, Dyer JR, Kramer LM, Raasch RH, Eron JJ, Cohen MS. Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemother 1999; 43:1817-1826.
13. Barau C, Delaugerre C, Braun J, et al. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. Antimicrob Agents Chemother 2010; 54:937-939.
14. Dumond JB, Reddy YS, Troiani L, et al. Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men. J Acquir Immune Defic Syndr 2008; 48:156-162.
15. Anderson JA, Ping LH, Dibben O, et al. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog 2010; 6:e1001053.
16. + T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50:283-289.
17. Hasse B, Ledergerber B, Hirschel B, et al. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51:1314-1322.
18. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011; 3:77ra29.